{'fraction_non_alphanumeric': 0.03245192307692308, 'fraction_numerical': 0.028846153846153848, 'mean_word_length': 4.9928057553956835, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Body weight increase: a side effect of zotepin (Nipolept)?].

During our clinical experience with the new neuroleptic drug zotepine we saw some cases of marked weight gain. This retrospective chart review of 110 cases consecutively admitted with the ICD-10 diagnosis of schizophrenia, schizoaffective or delusional disorder (F20-F25) in 1991 and 1992 was aimed at showing whether the weight gain is due to accidental observations or must be considered a side effect of this new drug. The data analysis of all cases treated longer than 2 weeks with a neuroleptic revealed that cases treated with zotepine showed a significant weight gain (3.6 kg) compared to those receiving the "classic" neuroleptics (1.3 kg). A possible link to the pharmacological profile of zotepine (high D2/HT2 affinity with antagonistic effect) is discussed.